The cytoskeleton reorganization and differentiation of HL-60 and K-562 human leukemia cell lines;Reorganizacja cytoszkieletu a róznicowanie się komórek linii ludzkich białaczek HL-60 i K-562

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 64-70

  Izdebska, Magdalena ^a   Grzanka, Alina ^a   Ostrowski, Maciej ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cytoskeleton; Differentiation; Human leukemia cells HL 60 and K 562

Indexed keywords

APOPTOSIS; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL TRANSFORMATION; CYTOSKELETON; HUMAN; INTERMEDIATE FILAMENT; METABOLISM; PATHOLOGY; REVIEW; TUMOR CELL LINE;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; ENGLISH ABSTRACT; HL-60 CELLS; HUMANS; INTERMEDIATE FILAMENTS;

EID: 33846113483     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Al-Shami A., Mahanna W., Naccache P.H.: Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak 2, Stat 3, and Stat 5b. J. Biol. Chem., 1998; 273: 1058-1063
2. Baker S.K., Goodwin S., Sur M., Tarnopolsky M.A.: Cytoskeletal myotoxicity from simvastatin and colchicines. Muscle Nerve., 2004; 30: 799-802
3. Basu S., Dunn A., Ward A.: G-CSF: function and modes of action. Int. J. Mol. Med., 2002; 10: 3-10
4. Ben-Efraim I., Zhou Q., Wiedmer T., Gerace L., Sims P.J.: Phospholipid scramblase 1 is imported into the nucleus by a receptor mediated pathway and interacts with DNA. Biochemistry, 2004; 43: 3518-3526
5. Biberfeld P., Ericsson J.L., Perlmann P., Raftell M.: Increased occurrence of cytoplasmic filaments in in vitro propagated rat liver epithelial cells. Exp. Cell Res., 1965; 39: 301-305
6. Bloemendal H., Pieper F.R.: Intermediated filaments: known structure, unknown function. Biochim. Biophys. Acta, 1989; 1007: 245-253
7. Borish L.C., Steinke J.W.: Cytokines and chemokines. J. Allergy Clin. Immunol., 2003; 111 (Suppl.2): S460-S475
8. Brackman D., Lund-Johansen F., Aarskog D.: Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leuk Res., 1995; 19: 57-64
9. Bruel A., Paschke S., Jainta S., Zhang Y., Vassy J., Rigaut J.P., Beil M.: Remodeling of vimentin cytoskeleton correlates with enhanced motility of promyelocytic leukemia cells during differentiation induced by retinoic acid. Anticancer Res., 2001; 21: 3973-3980
10. Byun Y., Chen F., Chang R., Trivedi M., Green K.J., Cryns V.L.: Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ., 2001; 8: 443-450
11. Chodniewicz D., Zhelev D.V.: Novel pathways of F-actin polymerization in the human neutrophil. Blood, 2003; 102: 2251-2258
12. Czyz M., Szuławska A.: Indukowane róznicowanie komórek białaczkowych linii K562. Post. Hig. Med. Dos̈w., 2005; 59: 82-97
13. Danova M., Aglietta M. Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors. Haematologica, 1997; 82: 622-629
14. Dellagi K., Brouet J.C.: Alteration of vimentin intermediate filaments expression during differentiation of HL60 and U937 human leukemic cell lines. Leuk. Res., 1984; 8: 611-616
15. Fabian I., Halperin D., Lefter S., Mittelman L., Altstock R.T., Seaon O., Tsarfaty I.: Alteration of actin organization by jaspamide inhibits ruffling, but not phagocytosis or oxidative burst, in HL-60 cells and human monocytes. Blood, 1999; 93: 3994-4005
16. Fabian I., Lass M., Kletter Y., Golde D.W.: Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: response to recombinant hematopoietic growth factors. Blood, 1992; 80: 788-794
17. Friend C., Scher W., Holland J.G., Sato T.: Hemoglobin synthesis in murine virus-induced leukemic cell in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA, 1971; 68: 378-382
18. Gigant B., Wang C., Ravelli R.B., Roussi F., Steinmetz M.O., Curmi P.A., Sobel A., Knossow M.: Structural basis for the regulation of tubulin by vinblastine. Nature, 2005; 435: 519-522
19. Grzanka A.: Wpływ wybranych cytostatyków na reorganizację białek cytoszkieletu linii komórek białaczek ludzkich K-562 i HL-60. Rozprawa habilitacyjna, Wydawnictwo uczelniane Akademii Medycznej im. L. Rydygiera, Bydgoszcz, 2002
20. Grzanka A., Grzanka D.: The influence of etoposide on the distribution of tubulin in human leukemia cell line HL-60. Med. Sci. Monit., 2003; 9(1): BR66-BR69
21. Grzanka A., Grzanka D., Orlikowska M.: Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem. Pharmacol., 2003; 66: 1611-1617
22. Grzanka A., Grzanka D., Orlikowska M., Zuryn A., Grzanka A.: Estimation of taxol influence on changes in tubulin and vimentin systems in K-562 and HL-60 cell lines by immunofluorescence microscopy. Neoplasma, 2005; 52: 193-198
23. Herrera R., Hubbell S., Decker S., Petruzzelli L.: A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K-562 cells. Exp. Cell Res., 1998; 238: 407-414
24. Huang S., Ingber D. E.: Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp. Cell Res., 2000; 261: 91-103
25. Huo X., Xu X.J., Chen Y.W., Yang H.W., Piao Z.X.: Filamentous-actins in human hepatocarcinoma cells with CLSM. World J. Gastroenterol., 2004; 10: 1666-1668
26. Jackson D.N., Foster D.A.: The enigmatic protein kinase Cd: complex roles in cell proliferation and survival. FASEB J., 2004; 18: 627-636
27. Jacob C., Leport M., Szilagyi C., Allen J.M., Bertrand C., Lagente V.: DMSO-treated HL60 cells: A model of neutrophil-like cells mainly expressing PDE4B subtype. Int. Immunopharmacol., 2002; 2: 1647-1656
28. Janmey P.A.: Creating a niche in the cytoskeleton: Actin reorganization by a protein kinase. Proc. Natl. Acad. Sci. USA, 2001; 98: 14745-14747
29. Jarvinen M., Andersson L.C., Virtanen J.: K562 erythroleukemia cells express cytokeratines 8, 18, and 19 and epithelial membrane antige that disappear after induced differentation. J. Cell Physiol.,1990; 143: 310-320
30. Ji Y., Studzinski G.P.: Retinoblastoma protein and CCAAT/enhancerbinding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res., 2004; 64: 370-377
31. Kambhampati S., Li Y., Verma A., Sassano A., Majchrzak B., Deb D.K., Parmar S., Giafis N., Kalvakolanu D.V., Rahman A., Uddin S., Minucci S., Tallman M.S., Fish E.N., Platanias L.C.: Activation of protein kinase C delta by all-trans-retinoic acid. J. Biol. Chem., 2003; 278: 32544-32551
32. Kanayasu-Toyoda T., Yamaguchi T., Uchida E., Hayakawa T.: Commitment of neutrophilic differentiation and proliferation of HL-60 cells coincides with expression of transferrin receptor. Effect of granulocyte colony stimulating factor on differentiation and proliferation. J. Biol. Chem., 1999; 274: 25471-25480
33. Katagiri K., Katagiri T., Kajiyama K., Yamamoto T., Yoshida T.: Tyrosine-phosphorylation of tubulin during monocytic differentiation of HL-60 cells. J. Immunol., 1993; 150: 585-593
34. Klymkowsky M.W.: Intermediate filaments: new proteins, some answers, more questions. Curr. Opin. Cell Biol., 1995; 7: 46-54
35. Krebs A., Goldie K.N., Hoenger A.: Structural rearrangements in tubulin following microtubule formation. EMBO Rep., 2005; 6: 227-232
36. Kutsuna H., Suzuki K., Kamata N., Kato T., Hato F., Mizuno K., Kobayashi H., Ishii M., Kitagawa S.: Actin reorganization and morphological changes in human neutrophils stimulated by TNF, GM-CSF, and G-CSF: The role of MAP kinases. Am. J. Physiol. Cell Physiol.,. 2004; 286: C55-C64
37. Kwiatkowska D., Kwiatkowska-Korczak J.: Kwas retinowy: jego metabolizm i mechanizm działania. Post. Biol. Kom., 1999; 26: 579-592
38. Kwiatkowska D., Kwiatkowska-Korczak J.: Heterodimeryczne receptory jądrowe. I. Receptory witamin i hormonów. Post. Biochem., 2000; 46: 125-129
39. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P.B.: Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther., 2001; 90: 105-156
40. Leung M.F., Sokoloski J.A., Sartorelli A.C.: Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentation of HL-60 leukemia cells. Cancer Res., 1992; 52: 949-954
41. Malinowska I.: Rola apoptozy w patogenezie i leczeniu nowotworów układu hematopoetycznego. Post. Hig. Med. Dos̈w., 2004; 58: 548-559
42. Marazzi L., Parodi M.T., Di Martino D., Ferrari S., Tonini G.P.; Coordinate change of c-myc, transferrin receptor and H3 gene expression precedens induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). Anticancer Res., 1991; 11: 947-952
43. Matsuhisa T., Mori Y.: Mode of differentiation of human promyelocytic leukemia cell line, HL-60, by 1alpha, 25-dihydroxyvitamin D3. Blood Cells Mol. Dis., 1995; 21: 42-48
44. Munshi C.B., Graeff R., Lee H.C.: Evidence for a causal role of CD38 expression in granulocytic differentiation of human HL-60 cells. J. Biol. Chem., 2002; 277: 49453-49458
45. Nowak J.Z. Zawilska J.B. Receptory i mechanizmy przekazywania sygnałów. PWN Warszawa 2004
46. Olins A.L., Herrmann H., Lichter P., Kratzmeier M., Doenecke D., Olins D.E: Nuclear envelope and chromatin compositional differences comparing undifferentiated and retinoic acid-and phorbol estertreated HL-60 cells. Exp. Cell Res., 2001; 268: 115-127
47. Olins A.L., Herrmann H., Lichter P., Olins D.E.: Retinoic acid differentiation of HL-60 cells promotes cytoskeletal polarization. Exp. Cell Res., 2000; 254: 130-142
48. Omary M.B., Coulombe P.A., McLeanW.H.: Intermediate filament proteins and their associated diseases. N. Engl. J. Med., 2004; 351: 2087-2100
49. Oshima R.G.: Apoptosis and keratin intermediate filaments. Cell Death Differ., 2002; 9: 486-492
50. Owen P.J., Johnson G.D., Lord J.M.: Protein kinase C-delta associates with vimentin intermediate filaments in differentiatiated HL60 cells. Exp. Cell Res., 1996; 225: 366-373
51. Pollard T.D.: Genomics, the cytoskeleton and motility. Nature, 2001; 409: 842-843
52. Rocchi P., Ferreri A.M., Magrini E., Perocco P.: Effect of butyrate analogues on proliferation and differentiation in human neuroblastoma cell lines. Anticancer Res, 1998; 18: 1099-1103
53. Ryves W.J., Dimitrijevic S., Gordge P.C., Evans F.J. HL-60 cell differentiation induced by phorbol-and 12-deoxyphorbol esters. Carcinogenesis, 1994; 15: 2501-2506
54. Sham R.L., Phatak P.D., Belanger K.A., Packman C.H.: Functional properties of HL60 cells matured with all-trans-retinoic acid and DMSO: differences in response to interleukin-8 and fMLP. Leuk. Res., 1995; 19: 1-6
55. Sham R.L., Phatak P.D., Belanger K.A., Packman C.H.: The effect of dexamethasone on functional properties of HL60 cells during all-trans retinoic acid induced differentiation. Are there implications for the retinoic acid syndrome? Blood Cells Mol. Dis., 1996; 22: 139-149
56. Simoni D., Rondanin R., Baruchello R., Roberti M., Rossi M., Grimaudo S., D' Alessandro N., Invidiata F.P., Tolomao M.: Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemiotherapeutic agents in oncology. Pure. Appl. Chem., 2001; 73: 1437-1444
57. Skalli O., Gabbiani G., Babai F., Seemayer T.A., Pizzolato G., Schurch W.: Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II Rhabdomyosarcomas. Am. J. Pathol., 1988; 130: 515-531
58. Takahashi N., Breitman T.R.: Retinoylation of vimentin in the human myeloid leukemia cell line HL60. J. Biol. Chem., 1994; 269: 5913-5917
59. Testa U., Torelli G.F., Riccioni R., Muta A.O, Militi S., Annino L., Mariani G., Guarini A., Chiaretti S., Ritz J., Mandelli F., Peschle C., Foa R.: Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors. Blood, 2002; 99: 4634-4637
60. Toivola D.M., Tao G.Z., Habtezion A., Liao J., Omary M.B.: Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends. Cell Biol., 2005; 15: 608-617
61. Ujihara M., Nomura K., Yamada O., Shibata N., Kobayashi M., Takano K.: Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: A study using a monocytic-differentiated HL60 subline. Free Radic Biol Med., 2001; 31: 1396-1404
62. Veselska R., Zitterbart K., Auer J., Neradil J.: Differentiation of HL-60 myeloid leukemia cells induced by all-trans retinoic acid is enhanced in combination with caffeic acid. Int. J. Mol. Med., 2004; 14: 305-310
63. Veselska R., Zitterbart K., Jelinkova S., Neradil J., Svoboda A.: Specific cytoskeleton changes during apoptosis accompanying induced differentiation of HL-60 myeloid leukemia cells. Oncol. Rep., 2003; 10: 1049-1058
64. Watts R.G.: Role of gelsolin in the formation and organization of tritonsoluble F-actin during myeloid differentiation of HL-60 cells. Blood, 1995; 85: 2212-2221
65. Zhao K.W., Li X., Zhao Q., Huang Y., Li D., Peng Z.G., Shen W.Z., Zhao J., Zhou Q., Chen Z., Sims P.J., Wiedmer T., Chen G.Q.: Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetateinduced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood, 2004;104: 3731-3738
66. Zheng M., Son M.Y, Park C., Park J.I., Jo E.K., Yoon W.H., Park S.K., Hwang B.D., Lim K.: Transcriptional repression of vimentin gene expression by pyrroline dithiocarbamate during 12-O-tetradecanoylphorbol-13-acetate-dependent differentiation of HL-60 cells. Oncol. Rep., 2005; 14: 713-717
67. Zitterbart K., Veselska R.: Effect of retinoic acid on the actin cytoskeleton in HL-60 cells. Neoplasma, 2001; 48: 456-461